Linked Life Data

7811249

Source:http://linkedlifedata.com/resource/pubmed/id/7811249

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7811249rdf:typepubmed:Citationlld:pubmed
pubmed-article:7811249lifeskim:mentionsumls-concept:C0009450lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C0009013lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C1550587lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C1335528lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C1527177lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C0441513lld:lifeskim
pubmed-article:7811249lifeskim:mentionsumls-concept:C1704788lld:lifeskim
pubmed-article:7811249pubmed:issue3lld:pubmed
pubmed-article:7811249pubmed:dateCreated1995-2-2lld:pubmed
pubmed-article:7811249pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7811249pubmed:abstractTextA DNA clone of HIV-1 containing the full-length infectious viral sequence was cleaved at a unique Nco I restriction site within the viral genome, and DNA fragments containing the 5' and 3' portions of the HIV genome were subcloned into separate plasmid vectors. The 5' 'half-virus' construct was further modified by incorporating a class IIS restriction site, Esp3I, near the 3' end of the protease gene of HIV. This site, in combination with a natural ApaI site near the 5' end of the protease gene, creates a convenient cassette shuttle vector in which the protease coding region can be easily replaced. Recombinant viruses containing protease genes either altered by site-directed mutagenesis or amplified from clinical or laboratory isolates can be reconstructed. The DNA fragment containing the protease gene is first subcloned into the 5' half-virus shuttle vector plasmid. Infectious recombinant virus is subsequently recovered by cotransfecting 5' and 3' half-virus plasmids linearized at their common Nco I sites into mammalian cells. This method was successfully applied to constructing viruses containing various substitutions in protease.lld:pubmed
pubmed-article:7811249pubmed:languageenglld:pubmed
pubmed-article:7811249pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7811249pubmed:citationSubsetIMlld:pubmed
pubmed-article:7811249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7811249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7811249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7811249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7811249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7811249pubmed:statusMEDLINElld:pubmed
pubmed-article:7811249pubmed:monthDeclld:pubmed
pubmed-article:7811249pubmed:issn0006-291Xlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:BachelerL TLTlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:WinslowD LDLlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:HorlickR ARAlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:ZagurskyR JRJlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:TritchR JRJlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:AckermanKKlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:AntonE DEDlld:pubmed
pubmed-article:7811249pubmed:authorpubmed-author:ScarnatiHHlld:pubmed
pubmed-article:7811249pubmed:issnTypePrintlld:pubmed
pubmed-article:7811249pubmed:day30lld:pubmed
pubmed-article:7811249pubmed:volume205lld:pubmed
pubmed-article:7811249pubmed:ownerNLMlld:pubmed
pubmed-article:7811249pubmed:authorsCompleteYlld:pubmed
pubmed-article:7811249pubmed:pagination1651-7lld:pubmed
pubmed-article:7811249pubmed:dateRevised2006-4-21lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:meshHeadingpubmed-meshheading:7811249-...lld:pubmed
pubmed-article:7811249pubmed:year1994lld:pubmed
pubmed-article:7811249pubmed:articleTitleConstruction of infectious molecular clones of HIV-1 containing defined mutations in the protease gene.lld:pubmed
pubmed-article:7811249pubmed:affiliationDuPont Merck Pharmaceutical Company, Wilmington, DE 19880-0026.lld:pubmed
pubmed-article:7811249pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7811249lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7811249lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7811249lld:pubmed